• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Rachel Cohrs Zhang

  • WASHINGTON, DC &#8211; DECEMBER 06:<br />
Dr. Vinay Prasad is an Assistant Professor of Medicine at Oregon health and science university. His research is on health policy, cost of drugs, evidence based medicine. In his practice, he takes care of patients with cancer. He is one of the panelists attending the Chasing Cancer Summit  in Washington, D.C.  on  December, 06, 2016.<br />
(Photo by Marvin Joseph/The Washington Post via Getty Images)Politics

    Ousted vaccine regulator Vinay Prasad to return to FDA

    By Rachel Cohrs Zhang and Bloomberg
  • Secretary of Health and Human Services Robert F. Kennedy Jr. with Medicare and Medicaid Administrator Mehmet Oz during a news conference on June 23, 2025. During the press conference Kennedy and Oz announced a plan they hope will streamline pre-authorizations for health procedures by health insurance providers. (Photo by SAUL LOEB / AFP) (Photo by SAUL LOEB/AFP via Getty Images)Health

    US health, tech officials to launch data-sharing plan

    By Rachel Cohrs Zhang, John Tozzi, and others
  • Health insurance concept,cost of health care concept.Politics

    Senate GOP restores Medicaid cuts to Trump tax package

    By Rachel Cohrs Zhang, Erin Durkin, and others
  • Peter Marks, director of the center for biologics evaluation and research at the U.S. Food and Drug Administration (FDA), speaks during a Senate Health, Education, Labor, and Pensions Committee hearing in Washington, D.C., U.S., on Tuesday, May 11, 2021. With the U.S. vaccination pace slowing, the White House&#8217;s top medical adviser said this week that using &#8220;trusted messengers&#8221; will be an important way to overcome hesitancy in some communities and get the nation closer to an 80% vaccination rate. Photographer: Greg Nash/The Hill/Bloomberg via Getty ImagesPolitics

    Top US vaccine official resigns citing RFK ‘misinformation’ push

    By Rachel Cohrs Zhang and Bloomberg
  • Robert F. Kennedy Jr.Politics

    RFK Jr. seeks to ban soda buying with food stamps in health push

    By Rachel Cohrs Zhang, Brett Pulley, and others
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Well
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.